Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Protection against experimental intraabdominal sepsis by two polysaccharide immunomodulators.

Tzianabos AO, Gibson FC 3rd, Cisneros RL, Kasper DL.

J Infect Dis. 1998 Jul;178(1):200-6.

2.

Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.

Tzianabos AO, Kasper DL, Cisneros RL, Smith RS, Onderdonk AB.

J Clin Invest. 1995 Dec;96(6):2727-31.

3.

Prevention of intraperitoneal adhesion formation using beta-glucan after ileocolic anastomosis in a rat bacterial peritonitis model.

Bedirli A, Gokahmetoglu S, Sakrak O, Ersoz N, Ayangil D, Esin H.

Am J Surg. 2003 Apr;185(4):339-43.

PMID:
12657386
4.

Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity.

Kalka-Moll WM, Tzianabos AO, Wang Y, Carey VJ, Finberg RW, Onderdonk AB, Kasper DL.

J Immunol. 2000 Jan 15;164(2):719-24.

5.

Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation.

Tzianabos AO, Onderdonk AB, Zaleznik DF, Smith RS, Kasper DL.

Infect Immun. 1994 Nov;62(11):4881-6.

6.

Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis.

Onderdonk AB, Shapiro ME, Finberg RW, Zaleznik DF, Kasper DL.

Rev Infect Dis. 1984 Mar-Apr;6 Suppl 1:S91-5. Review.

PMID:
6372042
8.

IL-2 mediates protection against abscess formation in an experimental model of sepsis.

Tzianabos AO, Russell PR, Onderdonk AB, Gibson FC 3rd, Cywes C, Chan M, Finberg RW, Kasper DL.

J Immunol. 1999 Jul 15;163(2):893-7.

9.

CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism.

Chung DR, Kasper DL, Panzo RJ, Chitnis T, Grusby MJ, Sayegh MH, Tzianabos AO.

J Immunol. 2003 Feb 15;170(4):1958-63. Erratum in: J Immunol. 2003 Apr 15;170(8):4411. Chtinis, T [corrected to Chitnis, T].

10.

Structure and function of Bacteroides fragilis capsular polysaccharides: relationship to induction and prevention of abscesses.

Tzianabos AO, Kasper DL, Onderdonk AB.

Clin Infect Dis. 1995 Jun;20 Suppl 2:S132-40. Review.

PMID:
7548535
11.

Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.

Kasper DL, Onderdonk AB, Crabb J, Bartlett JG.

J Infect Dis. 1979 Nov;140(5):724-31.

PMID:
528789
12.
13.

Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.

Onderdonk AB, Markham RB, Zaleznik DF, Cisneros RL, Kasper DL.

J Clin Invest. 1982 Jan;69(1):9-16.

14.
15.

Good and laudable pus.

Gorbach SL.

J Clin Invest. 1995 Dec;96(6):2545. No abstract available.

16.

Bacterial structure and functional relation to abscess formation.

Tzianabos AO, Onderdonk AB, Kasper DL.

Infect Agents Dis. 1994 Oct;3(5):256-65. Review.

PMID:
7866658
17.

Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.

Kasper DL, Onderdonk AB.

Scand J Infect Dis Suppl. 1982;31:28-33.

PMID:
6954635
18.

Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis.

Gibson FC 3rd, Onderdonk AB, Kasper DL, Tzianabos AO.

J Immunol. 1998 May 15;160(10):5000-6.

19.

Anti-infective effect of poly-beta 1-6-glucotriosyl-beta 1-3-glucopyranose glucan in vivo.

Onderdonk AB, Cisneros RL, Hinkson P, Ostroff G.

Infect Immun. 1992 Apr;60(4):1642-7.

20.

Surface antigens as virulence factors in infection with Bacteroides fragilis.

Kasper DL, Onderdonk AB, Polk BF, Bartlett JG.

Rev Infect Dis. 1979 Mar-Apr;1(2):278-90.

PMID:
549184
Items per page

Supplemental Content

Write to the Help Desk